ArticleClinical journal of gastroenterology2025

A case of complete remission by cabozantinib as an end-line treatment for advanced hepatocellular carcinoma.

Shuhei Nagashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.